DRUG REACTIONS UNDERREPORTED IN CHILDREN UNDER TWO

摘要

Adverse drug reactions (ADRs) are severely underreported in infants aged under two years, researchers have revealed, sparking a potential need for new ADR reporting systems. The team analysed ADRs reported through the Medicines and Healthcare products Regulatory Agency's (MHRA) Yellow Card system involving children aged under two years between 2001 and 2010.